Cargando…
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach
OBJECTIVE: Ectopic fat deposition is associated with increased tissue production of ceramides. Recent genetic mouse studies suggest that specific sphingolipid C16:0 ceramide produced by ceramide synthase 6 (CerS6) plays an important role in the development of insulin resistance. However, the therape...
Autores principales: | Raichur, Suryaprakash, Brunner, Bodo, Bielohuby, Maximilian, Hansen, Gitte, Pfenninger, Anja, Wang, Bing, Bruning, Jens C., Larsen, Philip Just, Tennagels, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407366/ https://www.ncbi.nlm.nih.gov/pubmed/30655217 http://dx.doi.org/10.1016/j.molmet.2018.12.008 |
Ejemplares similares
-
Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice
por: Ziegler, Nicole, et al.
Publicado: (2020) -
Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases
por: Raichur, Suryaprakash
Publicado: (2020) -
On ceramides, other sphingolipids and impaired glucose homeostasis()
por: Larsen, Philip J., et al.
Publicado: (2014) -
Mechanistic interplay between ceramide and insulin resistance
por: Reali, Federico, et al.
Publicado: (2017) -
Ceramide synthase CERS4 gene downregulation is associated with KRAS mutation in colorectal cancer
por: Hayama, Tamuro, et al.
Publicado: (2023)